title: Fish-oil supplementation reduces Ip(a) concentrations in type III dysbetalipoproteinemia.
authors.forename: J
authors.initials: J
authors.lastname: Dallongeville
authors.forename: E
authors.initials: E
authors.lastname: Selinger
authors.forename: J
authors.initials: J
authors.lastname: Davignon
authors.forename: S
authors.initials: S
authors.lastname: Lussier-Cacan
mesh_terms: D004042:Dietary Fats, Unsaturated / Q000627:therapeutic use*; D005395:Fish Oils / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006952:Hyperlipoproteinemia Type III / Q000097:blood* / Q000178:diet therapy; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000097:blood*
chemical_list: D004042:Dietary Fats, Unsaturated; D005395:Fish Oils; D017270:Lipoprotein(a); D008074:Lipoproteins